r/r DLBCLUniversity of Chicago Medicineaxicabtagene ciloleucelUniversity of ChicagoCD19-targeted chimeric antigen receptor (CAR) T-cell therapy
…ential of IFN-I-enhanced CAR T-cell therapies for patients with r/r DLBCL.Ethics Approval Deidentified patient biospecimens were collecte…